Judith Murrah was appointed by the Board of Directors as Chairperson and Chief Executive Officer on June 18, 2025, and was appointed President in December 2024.
Murrah joined Applied DNA in 2013 as Chief Information Officer, and was later promoted to Chief Operating Officer in 2021. In 2017, she was also appointed Secretary of the Company.
Prior to 2013, Ms. Murrah was previously the Senior Director of Information Technology at Motorola Solutions, which had acquired her former firm, Symbol Technologies. Her role at Motorola Solutions included overseeing the global IT program management office, financial and supplier operations and quality assurance. At Symbol Technologies, Ms. Murrah held leadership positions in product line management, global account sales, corporate and marketing communications and IT.
Ms. Murrah holds an MBA from Harvard Business School, and a B.S. in Industrial Engineering from the University of Rhode Island. She is an inventor on 14 U.S. patents.
Prior to being appointed as Chief Financial Officer of Applied DNA Sciences, Ms. Jantzen was the Controller for the Company since May of 2013. Ms. Jantzen is a certified public accountant with over 15 years financial and accounting experience.
Prior to joining the Company Ms. Jantzen was a senior manager at Marcum LLP, since June 9, 2014, where she managed multiple engagements and specialized in SEC policies, practices and procedures, including Sarbanes-Oxley compliance as well as valuations involving acquisitions. Ms Jantzen was named Who’s Who in Accounting/Audits by Long Island Business News in 2012.
President, LineaRx, Inc
Mr. Shorrock was appointed has served as the Company’s Chief Legal Officer and Executive Director of Business Development since April 2021, and as President of LineaRx, since December 2024. He leads the Company’s legal, regulatory, risk mitigation, intellectual property, and business development functions and has been instrumental in the development of the Company’s Linea™ DNA and Linea™ IVT platforms.
Mr. Shorrock previously served as general and intellectual property counsel to the Company from November 2016 through April 2019. Prior to rejoining the Company in April 2021, Mr. Shorrock was a member of the intellectual property groups of Lowndes, Drosdick, Doster, Kantor & Reed, P.A., and Allen, Dyer, Doppelt & Gilchrist, P.A. Earlier in his career Mr. Shorrock was an associate at several New Jersey-based law firms where he focused on intellectual property and complex commercial transactions.
Mr. Shorrock holds a B.A. in Biology from Franklin and Marshall College and a J.D. with a concentration in intellectual property from Seton Hall University Law School.